Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Authors
Keywords
-
Journal
THERAPEUTIC APHERESIS AND DIALYSIS
Volume 17, Issue 1, Pages 1-8
Publisher
Wiley
Online
2012-12-19
DOI
10.1111/1744-9987.12001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of cellular iron metabolism
- (2011) Jian Wang et al. BIOCHEMICAL JOURNAL
- Pumping iron: revisiting risks, benefits and strategies in treatment of iron deficiency in end-stage renal disease
- (2011) Neeraj Singh et al. CLINICAL NEPHROLOGY
- Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice
- (2011) Emilio Ramos et al. HEPATOLOGY
- Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice
- (2011) Elena Corradini et al. HEPATOLOGY
- Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD
- (2011) Peter Van Buren et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Hepcidin: clinical utility as a diagnostic tool and therapeutic target
- (2011) Daniel W. Coyne KIDNEY INTERNATIONAL
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
- (2010) Jodie L. Babitt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Determinants of Hepcidin in Patients on Maintenance Hemodialysis: Role of Inflammation
- (2010) Takahiro Kuragano et al. AMERICAN JOURNAL OF NEPHROLOGY
- Iron-Sensing Proteins that Regulate Hepcidin and Enteric Iron Absorption
- (2010) Mitchell D. Knutson Annual Review of Nutrition
- Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis
- (2010) K. E. Finberg et al. BLOOD
- Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
- (2010) B. J. Sasu et al. BLOOD
- Two to Tango: Regulation of Mammalian Iron Metabolism
- (2010) Matthias W. Hentze et al. CELL
- Intestinal Ferritin H Is Required for an Accurate Control of Iron Absorption
- (2010) Liviu Vanoaica et al. Cell Metabolism
- Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
- (2010) Karien van der Putten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
- (2010) Samira Lakhal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice
- (2010) Ivana De Domenico et al. JOURNAL OF CLINICAL INVESTIGATION
- Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients
- (2010) Bradley A. Ford et al. KIDNEY INTERNATIONAL
- Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents
- (2010) N. Tessitore et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Role of Hepcidin in Iron Metabolism
- (2009) Elizabeta Nemeth et al. ACTA HAEMATOLOGICA
- Hepcidin, the hormone of iron metabolism, is bound specifically to -2-macroglobulin in blood
- (2009) G. Peslova et al. BLOOD
- Hepcidin Assays: Ironing Out Some Details
- (2009) J. Malyszko Clinical Journal of the American Society of Nephrology
- Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
- (2009) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- Can the Response to Iron Therapy Be Predicted in Anemic Nondialysis Patients with Chronic Kidney Disease?
- (2009) S. Stancu et al. Clinical Journal of the American Society of Nephrology
- Hepcidin for Clinicians
- (2009) B. Young et al. Clinical Journal of the American Society of Nephrology
- Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy
- (2009) G. Weiss et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization
- (2009) J. J.C. Kroot et al. HAEMATOLOGICA
- Hepcidin targets ferroportin for degradation in hepatocytes
- (2009) G. Ramey et al. HAEMATOLOGICA
- Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
- (2009) D. R. Ashby et al. HAEMATOLOGICA
- HIF-2α, but not HIF-1α, promotes iron absorption in mice
- (2009) Maria Mastrogiannaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Iron-refractory iron deficiency anemia: new molecular mechanisms
- (2009) Yujie Cui et al. KIDNEY INTERNATIONAL
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
- (2009) Damien R. Ashby et al. KIDNEY INTERNATIONAL
- Iron metabolism in the anemia of chronic disease
- (2008) Günter Weiss BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Immunoassay for human serum hepcidin
- (2008) T. Ganz et al. BLOOD
- Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP
- (2008) J. P. Pinto et al. BLOOD
- Variability of ferritin measurements in chronic kidney disease; implications for iron management
- (2008) Bradley A. Ford et al. KIDNEY INTERNATIONAL
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
- (2008) Karin E Finberg et al. NATURE GENETICS
- Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry
- (2008) Dorine W. Swinkels et al. PLoS One
- Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
- (2007) L. Silvestri et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started